Close monitoring [i.e., of the maternal body temperature; fetal heart rate; C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin (PCT) levels; white blood cell (WBC) count; and amniotic fluid index] is required to detect chorioamnionitis symptoms and minimize the risk of neonatal and maternal complications [14,15]. This evidence concerns the gene CRP and chorioamnionitis.